NIP
CLBT icon

Norwood Investment Partners’s Cellebrite CLBT Stock Holding History

Norwood Investment Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-230,671
Closed -$4.27M – 16
2025
Q3 		$4.27M Buy
+230,671
New +$3.62M 3.68% 10

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Norwood Investment Partners's CLBT Position: Q4 2025 in Review

Norwood Investment Partners sold out of Cellebrite (CLBT) in Q4 2025, closing a stake of 230,671 shares — an estimated $4.27M sold.

Norwood Investment Partners first reported a position in CLBT in Q3 2025 and held it in 1 quarter. The position peaked at $4.27M in Q3 2025. 208 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • Norwood Investment Partners reported no remaining Cellebrite position as of Q4 2025 after selling out during the quarter.
  • Norwood Investment Partners sold 230,671 Cellebrite shares in Q4 2025, an estimated $4.27M.
  • Norwood Investment Partners first reported a position in Cellebrite in Q3 2025 and held it in 1 quarter.
  • Norwood Investment Partners's Cellebrite position peaked at $4.27M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on Norwood Investment Partners's 13F filing for Q4 2025, filed 17 Feb 2026.